Clinical trial
Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With…
NCT00473486 · University Hospital Muenster, Other · Terminated
Key facts
| NCT number | NCT00473486 |
|---|---|
| Title | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib |
| Official title | A Randomized (PhaseII), Double-blind, Multicenter Phase I/II Trial of Pemetrexed, Carboplatin Plus or Minus Sorafenib in the First-line Treatment of Patients With Stage IIIb or IV Non-Small Cell Lung Cancer |
| Acronym | PECASO |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | Bayer Industry Eli Lilly and Company |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | pemetrexed, carboplatin, sorafenib, placebo |
| Enrollment | 12 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Jan 1, 2010 |
| First posted | May 15, 2007 |
| Last update posted | Jan 27, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: